Changing the way you see cancer patients

Advancing patient care through innovative molecular diagnostics

bioTheranostics develops innovative molecular diagnostic oncology tests that provide valuable diagnostic and prognostic information to assist physicians in identifying the cancer therapies that will be most effective for each individual patient.

CancerTYPE ID^® provides molecular classification of uncertain or unknown cancers to guide physicians in determination of the primary cancer site and aid in the selection of therapeutic options.

Breast Cancer Index^SM predicts breast cancer recurrence risk based on proprietary molecular biomarkers, resulting in more appropriate treatment decisions.